secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2025-10-27T23:59:59+00:00
Accession:  0001437749-25-031819
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Health Q3 2025: TRCV up 8% to $141.7M; Adj EBITDA +11% YoY to $10.9M
------------------------------------------------------------------------

- Revenue $34.6M (+2% QoQ); GAAP net income $4.1M (12% of revenue); Adj net income $5.0M (14% of revenue).
- GAAP EPS $0.18; adjusted EPS $0.23 on 22.1M diluted shares.
- Cash from operations $13.8M (+46% YoY), representing 40% of total revenue.
- Total Recurring Contract Value (TRCV) $141.7M, up 8% YoY; fourth consecutive quarterly growth.
- CEO Trent Green cited strong sales and improved customer retention as growth drivers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774925031819/0001437749-25-031819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774925031819/nrc20251024_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-031819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer